share_log

HC Wainwright & Co. Maintains Buy on Kronos Bio, Lowers Price Target to $2.25

HC Wainwright & Co. Maintains Buy on Kronos Bio, Lowers Price Target to $2.25

HC Wainwright & Co.维持对Kronos Bio的买入,将目标股价下调至2.25美元
Benzinga ·  05/03 16:01

HC Wainwright & Co. analyst Robert Burns maintains Kronos Bio (NASDAQ:KRON) with a Buy and lowers the price target from $2.5 to $2.25.

HC Wainwright & Co. 分析师罗伯特·伯恩斯维持Kronos Bio(纳斯达克股票代码:KRON)的买入并将目标股价从2.5美元下调至2.25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发